35
total announcements
JUBLINGREA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹10,177 Cr
P/E (TTM)
33.2
P/E (Forward)
21.5
EPS (TTM)
₹19.44
52W Low
₹537.30
52W High
₹795.00
Dividend Yield
0.80%
Beta
0.28
Price / Book
3.3
Debt / Equity
25.3
Revenue (TTM)
₹4,650 Cr
Gross Margin
38.50%
Operating Margin
11.39%
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as required by SEBI regulations.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 26, 2026.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has informed the Exchange about the 7th Annual General Meeting (‘AGM’) scheduled to be held on August 26, 2026, through Video Conferencing/ Other Audio Visual Means. The Notice of the 7th AGM and the Annual Report for the financial year 2025-26 will be sent to all shareholders via electronic mode.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has informed the Exchange about the transcript of Investors’ Conference Call for un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, held on July 23, 2026. The company reported a strong start to FY 2027, delivering healthy financial performance in the first quarter with revenue growing by 25% year-on-year and EBITDA increasing by 36% year-on-year.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has submitted the unaudited standalone and consolidated financial results for the quarter ending June 30, 2026, as per the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has uploaded the audio recording of its investors conference call for the quarter ending June 30, 2026, on its website.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has reported its Q1 FY27 results, with revenue growing 25% YoY to ₹1,300 crore, EBITDA increasing 36% YoY to ₹209 crore, and PAT rising 41% YoY to ₹106 crore. The company's Speciality Chemical Business delivered revenue of ₹533 crore, up 11% YoY, with EBITDA margins of 26%. The company is confident of continuing its growth momentum in FY2027, led by Specialty Chemicals and Nutrition, alongside a recovery in Acetyls.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has announced its Q1 FY27 results, with revenue reaching ₹1,300 crore, a 25% YoY increase, driven by healthy volume growth and improved realizations. EBITDA increased to ₹209 crore, growing 36% YoY and 22% sequentially, while PAT stood at ₹106 crore, up 41% YoY and 22% QoQ.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has informed the Exchange about the outcome of its Board Meeting, where the Board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has submitted its financial results for the quarter ended June 30, 2026, and the independent auditor has reviewed the results, stating that nothing has come to their attention that would cause them to believe the results contain any material misstatement.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has granted 42,298 stock options to eligible employees under the Jubilant Ingrevia Employees Stock Option Scheme 2021.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has informed the Exchange about the schedule of an investor conference call to discuss unaudited financial results for the quarter ended June 30, 2026.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the substitution of the depository's name as the registered owner after verification and cancellation of physical share certificates.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has closed its trading window for insiders due to the upcoming announcement of financial results for the quarter ending June 30, 2026.
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has scheduled an in-person group meeting with analysts and institutional investors on Tuesday, June 30, 2026, in Bharuch. The company explicitly stated that discussions will be based on generally available information and will not involve any Unpublished Price Sensitive Information (UPSI). The schedule is subject to change due to exigencies. This is a routine disclosure as per SEBI regulations.